Infection of the liver with species of mycobacterium, most often mycobacterium tuberculosis. It is characterized by localized small tuberculous miliary lesions or tumor-like mass (tuberculoma), and ab...
Comprehensive, easy-to-understand information about this condition
How we create this content →Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Feb 9, 2026
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Feb 9, 2026
Helpful links for rare disease information and support
Questions that may be helpful when speaking with your healthcare team
Clinical profile data for this condition is not yet available. Phenotype information may still be loading below.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Feb 9, 2026
AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.
Organizations with approved therapies for this disease
No approved therapies yet
Research is ongoing — 1 company has orphan drug designations for this disease
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
AI-curated news mentioning hepatic tuberculosis
Updated Feb 11, 2026
The CDC is soliciting nominations for the Advisory Council for the Elimination of Tuberculosis, which will consist of 10 experts in various health fields. This initiative aims to enhance public health strategies against tuberculosis.
A study identifies rare STAT1 gene variants in Moroccan patients with tuberculosis, suggesting a genetic susceptibility to the disease. This research enhances understanding of host-pathogen interactions and may inform future therapeutic strategies.
A recent study explores the rare association between pulmonary mucosa-associated lymphoid tissue lymphoma and tuberculosis, highlighting significant diagnostic and therapeutic challenges. This research contributes to the understanding of complex interactions between these two conditions.
The CDC highlights the need for improved tuberculosis testing protocols following a school-based exposure incident in Lake County, Illinois. This report emphasizes the importance of addressing violence exposure in childhood as a factor in health outcomes.
The CDC reports on the performance of the CureTB program from 2016 to 2023, focusing on continuity of care for tuberculosis patients relocating internationally. This evaluation highlights the program's impact on patient management and health outcomes.